期刊文献+

ACS非血运重建患者抗血小板治疗依从性及其影响因素分析 被引量:4

Analysis of the Compliance of ACS Patients without Reascularization to Anti-platelet Therapy and Influential Factors
原文传递
导出
摘要 目的:研究急性冠状动脉综合征(ACS)非血运重建患者抗血小板治疗依从性的现状,分析其影响因素并提出对策。方法:采用自拟问卷形式进行调查,包括患者资料来源、医源性因素、药物因素等,评判患者用药依从性,应用统计方法分析上述因素与用药依从性的因果关系。结果:209例患者中,依从性好的32例,仅占15%。经济收入、文化程度、医疗保险、复诊次数、医师用药指导、出院时间等是影响患者用药依从性的主要因素。结论:ACS非血运重建患者依从性整体较差,医师可制订相应干预措施,从加强社区医师培训、加强患者用药指导、选择价格低的药物、减少药物副作用等方面提高患者依从性。 OBJECTIVE: To study the compliance of acute coronary syndrome (ACS) patients without reascularization to anti-platelet therapy, and to analyze influential factors and put forward countermeasures. METHODS: A self-designed questionnaire forms included data source of patients, iatrogenic factors and drug factors, etc. The compliance of patients was evaluated, and the causal relationship of above factors and medication compliance was analyzed statistically. RESULTS: Among 209 patients, 32 pa- tients had good compliance, accounting for 15%. The economic income, educational level, health insurance, follow-up visits, a doctor's medication guide and discharge time were the main influential factors of patients medication compliance. CONCLU- SIONS: ACS patients without reascularization treatment had poor compliance. Doctors can make corresponding intervention strategies, such as strengthening community doctor training and medication guidance for patients, choosing the drugs with low price, reducing the drug side effects, to improve patient's compliance.
作者 冯玲
出处 《中国药房》 CAS CSCD 2014年第30期2832-2834,共3页 China Pharmacy
基金 天津市武清区科技发展计划项目(No.wqkj201331)
关键词 急性冠状动脉综合征 抗血小板治疗 依从性 影响因素 干预措施 Acute coronary syndrome Anti-platelet therapy Compliance Influential factors Intervention measure
  • 相关文献

参考文献10

二级参考文献32

  • 1张新平,郑明节,袁帅.患者用药依从性及其影响因素分析[J].中国药房,2006,17(10):791-793. 被引量:91
  • 2仝其广,胡大一,王锦文,史旭波,李建勇,刘杰.冠心病二级预防药物长期治疗状况调查[J].中国医药导刊,2007,9(3):194-196. 被引量:32
  • 3胡大一,孙艺红.优化的药物治疗是冠心病二级预防的基石[J].中华内科杂志,2007,46(6):442-443. 被引量:42
  • 4He J, Gu D. Wu X, et al. Major cause of death among men and women in China. N Engl J Med, 2005, 353: 1124-1134.
  • 5Gao R, Patel A, Gao W, et al on behalf of the CPACS Investigators. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart, 2008, 94: 554-560.
  • 6Bi Y, Gao R, Patel A, et al. Evidence-based medication at the time of hospital discharge and 1 year after hospitalization : Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J, 2009, 157: 509-516.
  • 7Steg PG, Goldberg RJ, Gore JM, et al. GRACE Investigators. Baseline Characteristics, management practice, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in Global Registry of Acute Coronary Events (GRACE). Am J Cardiol ,2002, 90: 358-363.
  • 8Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatment and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. Euro Heart Survey ACS. Eur Heart J, 2002, 23 : 1190-1201.
  • 9Cannon CP, Weintranb WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategy in patients with unstable coronary syndromes treated with the glycoprotein II b/IIIa inhibitor tirofiban. N Engl J Med,2001, 344: 1979-1987.
  • 10Sueta CA,Chowdhury M,Boccuzzi SJ,et al.Analysis of the degree of undertreatment of hyperlipidiemia and congestive heart failure secondary to coronary artery disease.Am J Cardiol,1999;83:1303~1307

共引文献112

同被引文献17

引证文献4

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部